$27B/year scales trial capacity 25X, achieving 500 years of progress in 20
By eliminating the 8.2-year regulatory delay through pragmatic trials integrated into standard care
Highest ROI Action in History
In 30 seconds, you can save more lives than most people save in a lifetime.
Current clinical trial costs are 82 times higher than pragmatic trial alternatives.
Traditional clinical trials cost $41,000 per participant, exceeding median annual income in many countries.
The average cost to develop a new drug is $1.6 billion, reflected in pharmaceutical pricing.
Regulatory delays contribute to an estimated 21,000-120,000 preventable deaths per decade.
Current trial eligibility criteria exclude 85% of patients with the condition being studied.
95% of known diseases lack FDA-approved treatments, with research concentrated on the remaining 5%.
The average time from discovery to widespread clinical adoption is 17 years.
An estimated 166 billion potential treatment combinations remain untested with current methodologies.
Approximately 2 billion people worldwide suffer from diseases with inadequate treatment options.
No major disease has been cured in over 44 years, highlighting the need for new research paradigms.
HUMANITY SPENDS
THAN CURING ALL DISEASES COMBINED
CONSUMER REPORTS FOR DRUGS
A decentralized framework for drug assessment integrated into standard healthcare could both radically improve safety and allow patients to effortlessly participate in pragmatic decentralized clinical trials.
Find drugs, supplements, diets, devices - everything ranked by real-world effectiveness
Not marketing claims. Actual data from millions of real patients showing what works
One-click enrollment in pragmatic trials. Get paid to test treatments while helping humanity
Transparent rankings based on effectiveness, side effects, and cost-effectiveness
Enter your condition. Get a ranked list of every treatment ever tested.
See side-by-side outcomes: LDL reduction, survival rates, quality of life - actual numbers, not promises.
Choose based on data, not marketing budgets. Your body, your choice, informed by millions of data points.
Source information not available.
When you stop making people fill out paperwork and start letting them not die, something magical happens:
$463 returned for every $1 invested
Not a typo. Not a fever dream. Actual math.
This beats humanity's previous greatest hits in the "not dying" genre:
WHERE THE VALUE COMES FROM:
The Infinite ROI of Smart Reallocation
When you redirect money from bad stuff (like nuclear weapons) to good stuff (like medical research), the return on investment becomes infinite.
The 1% Treaty redirects military spending to subsidize patient participation in pragmatic clinical trials at zero net cost to society.
ROI = $147B / $0 = ∞
Other health interventions (shown for comparison) are invisible at this scale.
Where the $163B Comes From
The Part That Sounds Fake But Isn't:
Math says this is the best possible use of a billion dollars.
Math is rarely wrong about money. People are frequently wrong about money.
This is why math gets to make the rules.
Charts, breakdowns, and all the nerdy details
Adjust the slider to show how you’d split your country’s finite resources between the military (weapons and armed forces) and clinical trials to cure and treat disease.